Premium
CytoDyn Inc (QB) (CYDY)
USOTC
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that... CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.1074 | -27.6982591876 | 0.38775 | 0.39 | 0.27 | 4750724 | 0.30754861 | CS |
| 4 | 0.07645 | 37.4938695439 | 0.2039 | 0.4945 | 0.1911 | 4426786 | 0.28823542 | CS |
| 12 | 0.15205 | 118.511301637 | 0.1283 | 0.4945 | 0.1051 | 3869177 | 0.21809696 | CS |
| 26 | 0.12035 | 75.21875 | 0.16 | 0.4945 | 0.1031 | 3149764 | 0.18234311 | CS |
| 52 | 0.07535 | 36.756097561 | 0.205 | 0.4945 | 0.1031 | 2698902 | 0.17336545 | CS |
| 156 | -0.21965 | -43.93 | 0.5 | 1.3 | 0.1031 | 2260075 | 0.27551271 | CS |
| 260 | -0.73965 | -72.5147058824 | 1.02 | 10.01 | 0.1031 | 3116707 | 1.96063088 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
